Sterling IRB Celebrates 30th AnniversaryMay 18, 2021
Company Has Worked With Every Top 20 Pharma
ATLANTA–(BUSINESS WIRE)–Sterling IRB, the institutional review board leader in safeguarding the rights and welfare of clinical research participants, today commemorated its 30th anniversary with its rebranding. With a sole focus on delivering efficient, high-quality IRB services, Sterling IRB provides the expert guidance and exceptional service needed to accelerate research to market — as evidenced by the company’s 85% client retention rate.
“We are excited to mark this significant anniversary in the company’s history by investing in a brand which embodies the continued excellence we look forward to providing research participants and our clients well into the future,” said Ted Green, president and CEO of Sterling IRB. “As our longtime clients know, the brand communicates our commitment to safeguarding research and when organizations need a dedicated IRB, Sterling IRB is dedicated to providing expert guidance.”
Veteran-owned Sterling IRB is a longtime partner of healthcare systems that serve veterans, helping them find access to treatments and care while supporting clients’ study enrollment needs. As a part of our 30th anniversary celebration, Sterling is proud to sponsor the 22K Walk for Veterans Mental Health Awareness.
One of the only independently owned and operated IRBs in the industry today, Sterling IRB provides comprehensive central and local IRB services and is dedicated to avoiding the bureaucratic bottlenecks of larger review boards. Backed by a board of experts with over a century of combined experience, Sterling IRB focuses on understanding clients’ greatest challenges and helping them quickly pivot as regulatory landscapes continually shift.
From decentralized trial and IBC solutions to informed eConsent development and review involving vulnerable populations, Sterling IRB serves sponsors, CROs, and institutions from Phase I-IV and across all key therapeutic areas. With a top priority on protecting those research participants who play such a vital part in the development of new medicines and medical technologies, Sterling IRB protects the integrity of research and uncomplicates compliance.
About Sterling IRB
Sterling IRB has helped lead the way in safeguarding the rights and welfare of clinical research participants for more than 30 years. As part of the company’s commitment to streamlined processes, Sterling IRB provides a single-point-of-contact that focuses on clients’ specific needs. The company’s clients include pharmaceutical and biotechnology companies, clinical research organizations (CROs), research institutions, hospitals, federal agencies, and individual investigators. For more about Sterling IRB, visit sterlingirb.com.